Overnight Digest: Shares to Keep an Eye on March 13, 2026
Parth DSIJ / 12 Mar 2026 / Categories: Mindshare, Trending
Stay updated on March 13, 2026, market movements as NIFTY 50 and BSE Sensex closed lower amid Middle East tensions, rising oil prices, and weak global sentiment. Discover key shares to watch tomorrow, including corporate actions, buybacks, and Capex plans.
Equity markets closed in the red today, with investors turning cautious amid escalating tensions in the Middle East, a surge in crude oil prices, and broadly weak global sentiment.
The NIFTY 50 ended at 23,639.15, down 227.70 points (-0.95%), after opening at 23,674.85. The index saw a high of 23,833.15 and a low of 23,556.30.
Similarly, the BSE Sensex fell sharply by 829.29 points (-1.08%) to close at 76,034.42. The benchmark index had opened at 76,369.65 and traded in a range of 75,871.18 to 76,681.71.
Here is the complete list of shares that will remain in focus tomorrow following their announcements of corporate actions, including buyback proposals, and Capex Plans.
NTPC Green Energy Ltd informed that the third-party capacity of 270 MW out of the 1200 MW Khavda-II Solar PV Project in Gujarat has been declared on Commercial Operation with effect from 00:00 hrs on March 11, 2026. With this addition, the current commercial capacity of the NTPC Green Energy Ltd Group has increased from 9292.68 MW to 9562.68 MW.
Additionally, renewable energy stocks bucked the trend of the broader market fall, as investors rotated into companies linked to solar and wind power. Rising crude oil prices and geopolitical tensions in the Middle East strengthened investor interest in alternative energy plays.
NTPC Green shares surged to Rs 10.92, gaining 12.59 per cent today and closing at Rs 97.65.
Zydus Lifesciences Ltd, today announced its new companion diagnostics portfolio. The company will be launching Diasens™ and GlucoLive™, next-generation Continuous Glucose Monitoring (CGM) devices that combine artificial intelligence-powered insights with integrated remote care capabilities. The CGM system is designed to monitor glucose with an integrated AI layer to provide analytics and enable a closed-loop care ecosystem connecting patients, caregivers, and clinicians in real time.
Zydus Lifesciences shares fell to Rs 4.85, losing 0.53 per cent today and closing at Rs 916.90.
The Board of Directors of DCM Shriram at its meeting held today i.e., March 12, 2026, has approved the following:
- Equity Investment of up to Rs 87 crore, in one or more tranches, for a minimum 26 per cent equity stake in one or more Special Purpose Vehicles, to be created for setting up a Renewable Energy Power project for its Bharuch Plant.
- Proposal for incurring capital expenditure of up to Rs 130 crore, towards related infrastructure development.
DCM Shriram shares rose to Rs 25.90, gaining 2.62 per cent today and closing at Rs 1,015.70.
4. Jagsonpal Pharmaceuticals Ltd
On March 12, 2026, the Board of Directors of Jagsonpal Pharmaceutical Ltd approved a proposal to buy back up to 16,00,000 fully paid-up equity shares. This will be carried through the tender offer method, which would be subject to shareholders' approval.
The buyback is being offered at a price of Rs 250 per share, representing a 40 per cent premium to the current market price. The total consideration for the buyback is estimated at Rs 40 crore. The increase will raise promoter shareholdings from the current 67.2 per cent to 68.9 per cent, assuming buyback of 16 lakh equity shares.
Jagsonpal Pharmaceuticals shares rose to Rs 10.37, gaining 5.79 per cent today and closing at Rs 189.61.
Disclaimer: The article is for informational purposes only and not investment advice.